VCEL - Vericel Corporation
| Previous Close | 19.37 |
| Open | 19.40 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 800 |
| Day's Range | 19.07 - 19.56 |
| 52 Week Range | 6.80 - 20.02 |
| Volume | 389,289 |
| Avg. Volume | 721,068 |
| Market Cap | 831.835M |
| Beta (3Y Monthly) | 4.27 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.34 |
| Earnings Date | Feb 26, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.90 |
- GlobeNewswire•2 days ago
Vericel to Participate in Multiple Upcoming Investor Conferences
CAMBRIDGE, Mass., Feb. 20, 2019 -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced.
- GlobeNewswire•10 days ago
Vericel to Report Fourth-Quarter 2018 Financial Results on February 26, 2019
CAMBRIDGE, Mass., Feb. 12, 2019 -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced.
- GlobeNewswire•last month
Vericel to Present at the 21st Annual Needham Growth Conference
CAMBRIDGE, Mass., Jan. 11, 2019 -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced.
- Zacks•2 months ago
Bull or Bear: Your Investment Strategy for 2019
Whether you're a bull or a bear, it may be a good idea to go defensive about now.
- GlobeNewswire•2 months ago
Vericel Reports Publication of Outcomes Data From 954 Burn Patients Treated With Epicel in the Journal of Burn Care and Research
Vericel Corporation (VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the publication of outcomes data for 954 burn patients treated with Epicel® (cultured epidermal autografts) in the Journal of Burn Care and Research. The results demonstrated an increased survival rate for patients treated with Epicel when compared to results reported for patients in the National Burn Repository with comparable burns. Epicel is a permanent skin replacement produced from patients’ own cells and indicated for use in adult and pediatric patients who have deep dermal or full thickness burns comprising a total body surface area (TBSA) greater than or equal to 30%.
- Zacks•2 months ago
Zacks.com featured highlights include: Alteryx, Vericel, Mitek and Materialise
Zacks.com featured highlights include: Alteryx, Vericel, Mitek and Materialise
- Zacks•2 months ago
4 Stocks With Recent Price Strength to Maximize Your Gains
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
- Zacks•2 months ago
Has Vericel (VCEL) Outpaced Other Medical Stocks This Year?
Is (VCEL) Outperforming Other Medical Stocks This Year?
- Zacks•2 months ago
5 Nasdaq Composite Stocks That Braved the Index's Bloodbath
Despite a plummeting Nasdaq Composite, a few companies have survived the turbulence because of their internal strengths.
- Zacks•2 months ago
4 Healthcare Stocks That Popped More Than 100% in 2018
Players in the Healthcare sector gained from aging population, expanding government business, technological investment, strong demand for its product and services and industry consolidation.
- Zacks•2 months ago
Zacks.com featured highlights include: TEGNA, Vericel, Mobile Mini and Splunk
Zacks.com featured highlights include: TEGNA, Vericel, Mobile Mini and Splunk
- Zacks•2 months ago
4 Best Stocks That Flaunt Superb Earnings Acceleration
Studies show that a majority of successful stocks see acceleration in earnings before an uptick in the stock price.
- Insider Monkey•2 months ago
Do Hedge Funds Love Vericel Corp (VCEL)?
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 7% during October and average hedge fund losing about 3%. The Russell 2000, composed of smaller companies, performed even worse, trailing the S&P by about […]
Zacks•2 months agoVericel (VCEL) Flat As Market Sinks: What You Should Know
Vericel (VCEL) closed the most recent trading day at $17.10, making no change from the previous trading session.
- GlobeNewswire•2 months ago
New Research Coverage Highlights Verisk Analytics, Fortinet, Dine Brands Global, Oppenheimer, Vericel, and Century Communities — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Dec. 14, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- American City Business Journals•2 months ago
The Bay State's biggest stock gainer in 2018 is a marijuana company
In 2018, a small, Norwood-based firm in the burgeoning field of marijuana is likely to assume the title of best-performing publicly traded company in Massachusetts — by a wide margin.
- Simply Wall St.•3 months ago
Vericel Corporation’s (NASDAQ:VCEL) Path To Profitability
Vericel Corporation's (NASDAQ:VCEL): Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, markets, and sells patient-specific expanded cellular therapies to repair and regenerate damaged tissues and organs. With the latest Read More...
- Zacks•3 months ago
Small-Cap ETFs & Stocks to Outperform This Holiday Season (Revised)
The outperformance of the small-caps seems to hold true this year given that these pint-sized stocks are well insulated from international headwinds.
- Zacks•3 months ago
Zacks.com highlights: Helen of Troy, Vericel, Mobile Mini and Logitech International
Zacks.com highlights: Helen of Troy, Vericel, Mobile Mini and Logitech International
- Zacks•3 months ago
4 Best Stocks to Buy for Superb Earnings Acceleration
Studies have shown that a majority of successful stocks had seen acceleration in earnings before an uptick in the stock price.
- Zacks•3 months ago
The Zacks Analyst Blog Highlights: Vericel, Malibu Boats, Upland Software, QuinStreet and eGain
The Zacks Analyst Blog Highlights: Vericel, Malibu Boats, Upland Software, QuinStreet and eGain
- Zacks•3 months ago
Zacks.com highlights: Vericel, Mitek, Vanda Pharmaceuticals, Mosaic and Spirit Airlines
Zacks.com highlights: Vericel, Mitek, Vanda Pharmaceuticals, Mosaic and Spirit Airlines
- Zacks•3 months ago
Small-Cap ETFs & Stocks to Outperform This Holiday Season
The outperformance of the small-caps seems to hold true this year given that these pint-sized stocks are well insulated from international headwinds.
- Zacks•3 months ago
5 Stocks With Recent Price Strength to Strengthen Portfolio
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
